The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bode, U.
Right arrow Articles by Westermann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bode, U.
Right arrow Articles by Westermann, J.
The Journal of Immunology, 2002, 169: 6085-6091.
Copyright © 2002 by The American Association of Immunologists

The Fate of Effector T Cells In Vivo Is Determined During Activation and Differs for CD4+ and CD8+ Cells1

Ulrike Bode2,*, Andrea Sahle*, Gisela Sparmann{dagger}, Frauke Weidner* and Jürgen Westermann{ddagger}

* Center of Anatomy, Medical School of Hannover, Hannover, Germany; {dagger} Division of Gastroenterology, University of Rostock, Rostock, Germany; and {ddagger} Institute of Anatomy, Medical University of Luebeck, Luebeck, Germany

Effector T cells generated in the mesenteric lymph nodes (mLN) are known to accumulate in mLN and the tissue drained by them after circulating in the blood. Their accumulation is due less to preferential entry into mLN but more to preferential proliferation within mLN. The factors regulating the proliferation of effector T cells in vivo are unclear, and it is unknown whether they are different for CD4+ and CD8+ effector T cells. Rat T cells from mLN or peripheral lymph nodes (pLN) were stimulated polyclonally via the TCR and CD28 and injected i.v. into congenic recipients. Using three-color flow cytometry and immunohistochemistry, they were identified in mLN, pLN, and blood over time, and proliferation was determined by measuring bromodeoxyuridine incorporation. Only effector mLN T cells showed a significantly increased proliferation rate after entry into mLN compared with that in pLN (2.4 ± 1.8% vs 0.8 ± 0.4%). Proliferation among the injected cells was higher when they had contact with dendritic cells within mLN (9.0 ± 4.3%) than when they did not (4.1 ± 2.1%). Furthermore, effector mLN T cells which were observed 56 days after injection maintained the capacity for preferential proliferation within mLN. Interestingly, CD4+ effector mLN T cells proliferated at a higher rate (4.8 ± 0.7%), remaining in mLN, whereas CD8+ effector mLN T cells proliferated at a lower rate (3.3 ± 1.0%) and were able to leave the mLN into the blood. Elucidating the factors regulating the proliferation of effector T cells in vivo will help to modify their distribution for therapeutic purposes.




This article has been cited by other articles:


Home page
J ANIM SCIHome page
T. E. Burkey, K. A. Skjolaas, and J. E. Minton
BOARD-INVITED REVIEW: Porcine mucosal immunity of the gastrointestinal tract
J Anim Sci, April 1, 2009; 87(4): 1493 - 1501.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ahrendt, S. I. Hammerschmidt, O. Pabst, R. Pabst, and U. Bode
Stromal Cells Confer Lymph Node-Specific Properties by Shaping a Unique Microenvironment Influencing Local Immune Responses
J. Immunol., August 1, 2008; 181(3): 1898 - 1907.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kalies, P. Konig, Y.-M. Zhang, M. Deierling, J. Barthelmann, C. Stamm, and J. Westermann
Nonoverlapping Expression of IL10, IL12p40, and IFN{gamma} mRNA in the Marginal Zone and T Cell Zone of the Spleen after Antigenic Stimulation
J. Immunol., April 15, 2008; 180(8): 5457 - 5465.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
U. Bode, M. Lorchner, R. Pabst, K. Wonigeit, S. Overbeck, L. Rink, and J. Hundrieser
The superantigen-induced polarization of T cells in rat peripheral lymph nodes is influenced by genetic polymorphisms in the IL-4 and IL-6 gene clusters
Int. Immunol., January 1, 2007; 19(1): 81 - 92.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kalies, M. Blessenohl, J. Nietsch, and J. Westermann
T Cell Zones of Lymphoid Organs Constitutively Express Th1 Cytokine mRNA: Specific Changes during the Early Phase of an Immune Response
J. Immunol., January 15, 2006; 176(2): 741 - 749.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Schif-Zuck, J. Westermann, N. Netzer, Y. Zohar, M. Meiron, G. Wildbaum, and N. Karin
Targeted Overexpression of IL-18 Binding Protein at the Central Nervous System Overrides Flexibility in Functional Polarization of Antigen-Specific Th2 Cells
J. Immunol., April 1, 2005; 174(7): 4307 - 4315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Westermann, U. Bode, A. Sahle, U. Speck, N. Karin, E. B. Bell, K. Kalies, and A. Gebert
Naive, Effector, and Memory T Lymphocytes Efficiently Scan Dendritic Cells In Vivo: Contact Frequency in T Cell Zones of Secondary Lymphoid Organs Does Not Depend on LFA-1 Expression and Facilitates Survival of Effector T Cells
J. Immunol., March 1, 2005; 174(5): 2517 - 2524.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.